Clinical Trials
9 trialsNCT03412643 2023-03-06
FB-12
NSABP Foundation Inc
Phase 2 Unknown
NCT01547741 2022-04-14
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT05158608 2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3 Unknown
NCT00408408 2017-09-18
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
NSABP Foundation Inc
Phase 3 Unknown
NCT00486668 2016-06-06
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT02270307 2014-10-21
MSC-CY
National Research Center for Hematology, Russia
Phase 2/3 Unknown
NCT02156726 2014-06-05
Q-lite
Czech CLL Study Group
Unknown
NCT00737685 2012-03-26
Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)
The Korean Society of Pediatric Hematology Oncology
Phase 2 Unknown
NCT01532856 2012-02-15
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Grupo de Estudos Multicentricos em Onco-Hematologia
Phase 3 Unknown